Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

CHE | Chemed Corp.

Healthcare | Medical Care Facilities | USA | NYSE

Index	-	P/E	34.65	EPS (ttm)	15.00	Insider Own	2.56%	Shs Outstand	14.87M	Perf Week	1.52%
Market Cap	7.84B	Forward P/E	23.28	EPS next Y	22.32	Insider Trans	-5.46%	Shs Float	14.69M	Perf Month	1.08%
Income	226.50M	PEG	3.98	EPS next Q	4.90	Inst Own	96.41%	Short Float / Ratio	3.02% / 6.22	Perf Quarter	-4.06%
Sales	2.19B	P/S	3.58	EPS this Y	1.15%	Inst Trans	1.15%	Short Interest	0.44M	Perf Half Y	-1.44%
Book/sh	63.42	P/B	8.20	EPS next Y	11.73%	ROA	16.07%	Target Price	565.33	Perf Year	16.64%
Cash/sh	10.60	P/C	49.01	EPS next 5Y	8.70%	ROE	27.67%	52W Range	430.16 - 574.66	Perf YTD	1.82%
Dividend	1.54	P/FCF	27.82	EPS past 5Y	23.05%	ROI	21.49%	52W High	-9.56%	Beta	0.51
Dividend %	0.30%	Quick Ratio	1.08	Sales past 5Y	5.13%	Gross Margin	31.39%	52W Low	20.82%	ATR	8.15
Employees	14167	Current Ratio	1.11	Sales Q/Q	4.24%	Oper. Margin	13.92%	RSI (14)	58.47	Volatility	1.50% 1.53%
Optionable	Yes	Debt/Eq	0.15	EPS Q/Q	-20.25%	Profit Margin	10.36%	Rel Volume	1.81	Prev Close	522.00
Shortable	Yes	LT Debt/Eq	0.11	Earnings	Jul 26 AMC	Payout	8.95%	Avg Volume	71.30K	Price	519.70
Recom	1.00	SMA20	2.14%	SMA50	0.75%	SMA200	-0.91%	Volume	129,115	Change	-0.44%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-11-20	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$448 → $535
Nov-01-19	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform	$490
Sep-06-19	Reiterated	BofA/Merrill	Buy	$470 → $500
Oct-12-18	Initiated	BofA/Merrill	Buy	$390
Aug-28-17	Initiated	KeyBanc Capital Mkts	Sector Weight
Nov-01-16	Reiterated	RBC Capital Mkts	Sector Perform	$162 → $148
Jul-27-16	Reiterated	RBC Capital Mkts	Sector Perform	$136 → $162
May-02-16	Reiterated	RBC Capital Mkts	Sector Perform	$135 → $136
Oct-26-15	Reiterated	RBC Capital Mkts	Sector Perform	$129 → $154
Oct-26-15	Reiterated	Oppenheimer	Outperform	$150 → $152
Sep-22-15	Reiterated	Oppenheimer	Outperform	$147 → $150
Jul-27-15	Reiterated	RBC Capital Mkts	Sector Perform	$110 → $129
Feb-19-15	Reiterated	Oppenheimer	Outperform	$122 → $123
Sep-23-14	Reiterated	Oppenheimer	Outperform	$110 → $115
Jun-10-14	Reiterated	RBC Capital Mkts	Sector Perform	$70 → $74
May-01-14	Reiterated	Oppenheimer	Outperform	$90 → $92
Sep-10-13	Reiterated	Deutsche Bank	Hold	$70 → $63
Mar-04-11	Reiterated	Barclays Capital	Underweight	$65 → $9
Feb-17-11	Reiterated	RBC Capital Mkts	Sector Perform	$53 → $67
Feb-17-11	Reiterated	Oppenheimer	Outperform	$67 → $72

Show Previous Ratings

Sep-18-23 11:40AM	DVA or CHE: Which Is the Better Value Stock Right Now? (Zacks)
Sep-14-23 10:48AM	Chemed (CHE) Faces Macroeconomic Woes, Tough Competition (Zacks)
Aug-31-23 11:40AM	OPCH vs. CHE: Which Stock Is the Better Value Option? (Zacks)
Aug-15-23 01:20PM	OPCH vs. CHE: Which Stock Should Value Investors Buy Now? (Zacks)
Aug-08-23 06:28AM	Daily Vickers Top Buyers & Sellers for 08/08/2023 (Argus Research)
07:08AM	Loading…
Aug-07-23 07:08AM	Are Chemed Corporation (NYSE:CHE) Investors Paying Above The Intrinsic Value? (Simply Wall St.)
Aug-04-23 11:56AM	Chemed Corporation Declares Quarterly Dividend of 40 Cents (Business Wire)
Jul-27-23 08:23AM	Chemed (CHE) Q2 Earnings Miss Estimates, '23 EPS View Down (Zacks) -8.10%
Jul-26-23 10:00PM	Chemed (CHE) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
06:45PM	Chemed (CHE) Q2 Earnings and Revenues Lag Estimates (Zacks)
05:43PM	Chemed: Q2 Earnings Snapshot (AP Finance)
04:15PM	Chemed Reports Second-Quarter 2023 Results (Business Wire)
Jul-21-23 09:56AM	Chemed's (NYSE:CHE) 12% CAGR outpaced the company's earnings growth over the same five-year period (Simply Wall St.)
Jul-20-23 11:40AM	DVA vs. CHE: Which Stock Is the Better Value Option? (Zacks)
Jul-12-23 12:00PM	Chemed To Report Second-Quarter 2023 Earnings July 26, Related Conference Call To Be Held On July 27 (Business Wire)
08:25AM	Loading…
Jul-10-23 08:25AM	Here's Why You Should Retain Chemed (CHE) Stock for Now (Zacks)
Jun-21-23 08:00PM	CHE: Raising target price to $574.00 (Argus Research)
Jun-14-23 09:53AM	4 Stocks to Hold in a Challenging Outpatient Home Health Industry (Zacks)
Jun-06-23 08:40AM	Strength Seen in Amedisys (AMED): Can Its 15.4% Jump Turn into More Strength? (Zacks)
Jun-05-23 08:56AM	Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean (Simply Wall St.)
Jun-01-23 12:00PM	Chemed Corporation to Present at the Jefferies 2023 Healthcare Conference (Business Wire)
May-24-23 09:03AM	Here's Why You Should Retain Chemed (CHE) Stock for Now (Zacks)
May-15-23 02:43PM	Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend (Business Wire)
May-10-23 12:00PM	Chemed Corporation to Present at the 2023 RBC Global Healthcare Conference (Business Wire)
11:40AM	DVA vs. CHE: Which Stock Should Value Investors Buy Now? (Zacks)
May-09-23 06:40AM	Daily Vickers Top Buyers & Sellers for 05/09/2023 (Argus Research)
May-03-23 12:00PM	Chemed Corporation to Present at the Bank of America Merrill Lynch 2023 Health Care Conference (Business Wire)
May-02-23 03:14PM	AmerisourceBergen (ABC) Beats on Q2 Earnings, Ups '23 EPS View (Zacks)
06:39AM	Stryker (SYK) Q1 Earnings Beat Estimates, Volume Improves (Zacks)
Apr-30-23 09:13AM	Is Chemed Corporation's (NYSE:CHE) Recent Stock Performance Tethered To Its Strong Fundamentals? (Simply Wall St.)
11:24AM	Loading…
Apr-28-23 11:24AM	DexCom (DXCM) Q1 Earnings Beat Estimates, Volumes Remain Strong (Zacks)
Apr-27-23 11:47AM	Baxter (BAX) Beats on Q1 Earnings, Ups '23 EPS View (Zacks)
10:45AM	West Pharmaceutical (WST) Q1 Earnings Beat, Order Book Strong (Zacks)
09:33AM	Chemed (CHE) Lags Q1 Earnings Estimates, Reaffirms Guidance (Zacks)
06:11AM	CONMED (CNMD) Beats on Q1 Earnings, Ups '23 EPS View (Zacks)
Apr-26-23 08:00PM	CHE: Raising target price to $589.00 (Argus Research)
06:25PM	Chemed (CHE) Q1 Earnings Lag Estimates (Zacks)
04:15PM	Chemed Reports First-Quarter 2023 Results (Business Wire)
Apr-24-23 12:15PM	Chemed To Report First-Quarter 2023 Earnings April 26, Related Conference Call To Be Held On April 27 (Business Wire)
Apr-17-23 11:40AM	EHC vs. CHE: Which Stock Is the Better Value Option? (Zacks)
Mar-31-23 12:52PM	Here's Why Investors Should Hold Ensign Group (ENSG) Stock Now (Zacks)
Mar-30-23 06:36AM	Daily Vickers Top Buyers & Sellers for 03/30/2023 (Argus Research)
Mar-29-23 11:40AM	PNTG vs. CHE: Which Stock Should Value Investors Buy Now? (Zacks)
Mar-24-23 07:07AM	Zacks Industry Outlook Highlights Chemed, Addus HomeCare, RadNet and The Pennant Group (Zacks)
Mar-23-23 10:55AM	4 Promising Stocks From a Challenging Outpatient Home Health Industry (Zacks)
Mar-22-23 11:13AM	Chemed (CHE) Up on Roto-Rooter Sales Growth, Strong Admissions (Zacks)
Mar-15-23 09:40AM	Is Bellicum Pharmaceuticals (BLCM) Stock Outpacing Its Medical Peers This Year? (Zacks)
Mar-13-23 11:40AM	PNTG or CHE: Which Is the Better Value Stock Right Now? (Zacks)
Mar-01-23 12:00PM	Chemed Corporation to Present at the Oppenheimer 33rd Annual Healthcare Conference (Business Wire)
Feb-25-23 07:18AM	Chemed Full Year 2022 Earnings: EPS Misses Expectations (Simply Wall St.)
12:47AM	Q4 2022 Chemed Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-24-23 11:40AM	PNTG vs. CHE: Which Stock Is the Better Value Option? (Zacks)
07:41AM	Chemed (CHE) Q4 Earnings Beat Estimates, Margins Contract (Zacks)
Feb-23-23 06:50PM	Chemed (CHE) Tops Q4 Earnings and Revenue Estimates (Zacks)
04:15PM	Chemed Reports Fourth-Quarter 2022 Results (Business Wire)
Feb-17-23 12:19PM	Chemed Corporation Declares Quarterly Dividend of 38 Cents (Business Wire)
Feb-11-23 08:29AM	Investors in Chemed (NYSE:CHE) have made a respectable return of 100% over the past five years (Simply Wall St.)
Feb-09-23 12:00PM	Chemed To Report Fourth-Quarter 2022 Earnings February 23, Related Conference Call To Be Held On February 24 (Business Wire)
Jan-21-23 10:00AM	This Low-Key Stock Jumped Nearly 600% Over the Last Decade (Motley Fool)
Dec-27-22 06:46AM	Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns (Simply Wall St.)
Dec-01-22 11:40AM	PNTG or CHE: Which Is the Better Value Stock Right Now? (Zacks)
Nov-29-22 11:25AM	Chemed Corporation to Present at the BofA Securities 2022 Virtual Home Care Conference (Business Wire)
Nov-21-22 07:27AM	Is Chemed Corporation's (NYSE:CHE) Recent Stock Performance Tethered To Its Strong Fundamentals? (Simply Wall St.)
Nov-08-22 11:40AM	PNTG vs. CHE: Which Stock Is the Better Value Option? (Zacks)
Nov-04-22 11:41AM	Chemed Corporation Declares Quarterly Dividend of 38 Cents (Business Wire)
Nov-03-22 11:25AM	Chemed (CHE) Q3 Earnings Surpass Estimates, EPS View Up (Zacks)
Oct-31-22 06:25PM	Chemed (CHE) Q3 Earnings Surpass Estimates (Zacks)
04:15PM	Chemed Reports Third-Quarter 2022 Results - Increases 2022 Earnings Guidance (Business Wire)
12:00PM	Chemed Corporation to Present at the 2022 Credit Suisse Healthcare Conference (Business Wire)
Oct-26-22 12:10PM	Why Chemed (CHE) is Poised to Beat Earnings Estimates Again (Zacks)
Oct-24-22 10:00AM	Earnings Preview: Chemed (CHE) Q3 Earnings Expected to Decline (Zacks)
Oct-17-22 06:09PM	Seeking Recession-Proof Stocks? Here Are 2 Names Analysts Like (TipRanks)
12:00PM	Chemed To Report Third-Quarter 2022 Earnings October 31, Related Conference Call To Be Held On November 1 (Business Wire)
Oct-10-22 06:44AM	Calculating The Intrinsic Value Of Chemed Corporation (NYSE:CHE) (Simply Wall St.)
Oct-07-22 08:38AM	Is the Options Market Predicting a Spike in Chemed (CHE) Stock? (Zacks)
Oct-06-22 12:49PM	Here's Why You Should Retain Chemed (CHE) Stock for Now (Zacks)
Sep-29-22 10:24AM	Option Care (OPCH) Stock Jumps 8.9%: Will It Continue to Soar? (Zacks)
Sep-28-22 11:41AM	Chemed (CHE) Roto-Rooter Business Grows, VITAS Admission Dips (Zacks)
Sep-04-22 08:44AM	Investing in Chemed (NYSE:CHE) five years ago would have delivered you a 149% gain (Simply Wall St.)
Sep-02-22 12:46PM	Chemed's (CHE) Roto-Rooter Growth Aids, Macro Challenges Ail (Zacks)
Sep-01-22 12:52PM	Here's Why You Should Hold on to Chemed (CHE) Stock Now (Zacks)
Aug-31-22 11:40AM	PNTG vs. CHE: Which Stock Should Value Investors Buy Now? (Zacks)
Aug-12-22 06:07AM	The Zacks Analyst Blog Highlights H&R Block, Chemed, Suncor Energy, Open Text and Essent Group (Zacks)
Aug-11-22 08:04AM	5 Stocks in Focus That Recently Hiked Their Dividends (Zacks)
Aug-05-22 12:36PM	Chemed Corporation Declares Quarterly Dividend of 38 Cents (Business Wire)
Jul-29-22 01:57PM	Chemed (CHE) Q2 Earnings Surpass Estimates, Margins Grow (Zacks)
Jul-27-22 05:55PM	Chemed (CHE) Q2 Earnings Surpass Estimates (Zacks)
04:15PM	Chemed Reports Second-Quarter 2022 Results (Business Wire)
Jul-22-22 08:38AM	Oak Street Health, Inc. (OSH) Surges 5.2%: Is This an Indication of Further Gains? (Zacks)
Jul-20-22 07:05AM	We Like Chemed's (NYSE:CHE) Returns And Here's How They're Trending (Simply Wall St.)
Jul-19-22 12:25PM	Here's Why You Should Retain Chemed (CHE) Stock For Now (Zacks)
Jul-06-22 12:00PM	Chemed To Report Second-Quarter 2022 Earnings July 27, Related Conference Call To Be Held On July 28 (Business Wire)
Jun-29-22 08:00AM	Chemed Corporation Announces a Five-Year $550 Million Amended and Restated Senior Secured Credit Facility (Business Wire)
Jun-20-22 07:52AM	Chemed (CHE) Surges 3.3%: Is This an Indication of Further Gains? (Zacks)
Jun-14-22 07:35AM	Could The Market Be Wrong About Chemed Corporation (NYSE:CHE) Given Its Attractive Financial Prospects? (Simply Wall St.)
Jun-13-22 12:20PM	Here's Why Investors Should Retain Chemed (CHE) Stock Now (Zacks)
Jun-02-22 12:00PM	Chemed Corporation to Present at the Jefferies 2022 Healthcare Conference (Business Wire)
May-27-22 01:12PM	Amedisys (AMED) Down 11% Since Last Earnings Report: Can It Rebound? (Zacks)
May-16-22 02:13PM	Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend (Business Wire)
May-11-22 12:00PM	Chemed Corporation to Present at the 2022 RBC Capital Markets Global Healthcare Conference (Business Wire)

Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through the VITAS and Roto-Rooter segments. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment includes plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers. The company was founded in 1970 and is headquartered in Cincinnati, OH.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MCNAMARA KEVIN J	president and CEO	Aug 04	Option Exercise	413.19	3,000	1,239,570	118,571	Aug 07 10:28 AM
MCNAMARA KEVIN J	president and CEO	Aug 03	Sale	516.43	4,000	2,065,720	115,571	Aug 07 10:28 AM
Westfall Nicholas Michael	Executive Vice President	Jun 01	Option Exercise	413.19	12,670	5,235,117	20,346	Jun 05 03:10 PM
Westfall Nicholas Michael	Executive Vice President	Jun 01	Option Exercise	413.19	1,330	549,543	7,676	Jun 01 02:36 PM
Westfall Nicholas Michael	Executive Vice President	Jun 01	Sale	533.70	12,670	6,761,979	7,676	Jun 05 03:10 PM
Westfall Nicholas Michael	Executive Vice President	May 30	Sale	540.34	1,330	718,652	6,346	Jun 01 02:36 PM
GRACE PATRICK P	Director	May 26	Sale	544.24	294	160,007	3,270	May 30 01:52 PM
MCNAMARA KEVIN J	president and CEO	May 05	Sale	549.34	4,000	2,197,360	119,571	May 08 01:02 PM
MCNAMARA KEVIN J	president and CEO	May 03	Option Exercise	413.19	31,500	13,015,485	150,611	May 03 02:34 PM
MCNAMARA KEVIN J	president and CEO	May 02	Option Exercise	413.19	3,500	1,446,165	122,113	May 02 11:52 AM
MCNAMARA KEVIN J	president and CEO	Mar 28	Sale	526.27	3,000	1,578,810	118,613	Mar 29 10:25 AM
WILLIAMS DAVID PATRICK	executive vice president & CFO	Mar 20	Sale	523.25	4,000	2,093,000	20,443	Mar 21 01:54 PM
MCNAMARA KEVIN J	president and CEO	Mar 09	Sale	507.32	2,000	1,014,640	121,613	Mar 10 11:31 AM
MCNAMARA KEVIN J	president and CEO	Feb 17	Option Exercise	515.12	4,245	2,186,684	125,509	Feb 22 01:47 PM
WILLIAMS DAVID PATRICK	executive vice president & CFO	Feb 17	Option Exercise	515.12	1,632	840,676	25,157	Feb 22 01:48 PM
Westfall Nicholas Michael	Executive Vice President	Feb 17	Option Exercise	515.12	1,224	630,507	8,224	Feb 22 03:10 PM
LEE SPENCER S	executive vice president	Feb 17	Option Exercise	515.12	815	419,823	25,163	Feb 22 03:11 PM
Witzeman Michael D	vice president and controller	Feb 17	Option Exercise	515.12	669	344,615	2,569	Feb 22 02:27 PM
Judkins Brian C	VP and Chief Legal Officer	Feb 17	Option Exercise	515.12	587	302,375	650	Feb 22 02:46 PM
HUTTON THOMAS C	vice president	Feb 17	Option Exercise	515.12	326	167,929	37,065	Feb 22 02:14 PM
HUTTON THOMAS C	vice president	Nov 29	Option Exercise	413.19	2,533	1,046,610	38,951	Nov 30 10:17 AM
MCNAMARA KEVIN J	president and CEO	Nov 21	Sale	505.76	2,000	1,011,520	121,264	Nov 22 10:59 AM
LEE SPENCER S	executive vice president	Nov 16	Option Exercise	306.70	8,000	2,453,600	30,701	Nov 16 02:11 PM
WILLIAMS DAVID PATRICK	executive vice president & CFO	Nov 14	Option Exercise	306.70	15,500	4,753,850	35,660	Nov 14 03:29 PM
WILLIAMS DAVID PATRICK	executive vice president & CFO	Nov 10	Sale	497.31	8,000	3,978,480	20,160	Nov 14 03:29 PM
Witzeman Michael D	vice president and controller	Nov 10	Sale	498.47	736	366,874	1,900	Nov 14 10:09 AM
WILLIAMS DAVID PATRICK	executive vice president & CFO	Nov 09	Sale	491.00	500	245,500	28,160	Nov 10 02:35 PM
LEE SPENCER S	executive vice president	Nov 08	Sale	490.09	2,000	980,180	22,701	Nov 08 02:02 PM
WILLIAMS DAVID PATRICK	executive vice president & CFO	Nov 08	Sale	493.00	1,000	493,000	28,660	Nov 10 02:35 PM
Witzeman Michael D	vice president and controller	Nov 04	Option Exercise	306.70	6,900	2,116,230	8,086	Nov 04 02:21 PM
MCNAMARA KEVIN J	president and CEO	Nov 04	Option Exercise	306.70	5,000	1,533,500	123,264	Nov 04 02:39 PM
Westfall Nicholas Michael	Executive Vice President	Nov 03	Option Exercise	306.70	13,500	4,140,450	20,500	Nov 04 03:15 PM
Westfall Nicholas Michael	Executive Vice President	Nov 03	Sale	477.19	13,500	6,442,065	7,000	Nov 04 03:15 PM
MCNAMARA KEVIN J	president and CEO	Nov 03	Sale	482.90	2,000	965,800	122,235	Nov 04 02:39 PM
Witzeman Michael D	vice president and controller	Nov 03	Sale	482.62	1,300	627,406	1,186	Nov 04 02:21 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CHE | Chemed Corp.

Upgrade your FINVIZ experience